Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)

Journal of the American College of Cardiology

Volumn 12, Issue 3, 1988, Pages 581-587

  Neuhaus, Karl Ludwig ^a   Tebbe, Ulrich ^a   Gottwik, Martin ^a   Weber, Michael A J ^a   Feuerer, Werner ^a   Niederer, Walter ^a   Haerer, Winfried ^a   Praetorius, Frank ^a   Grosser, Klaus Dieter ^a   Huhmann, Wolfgang ^a   Hoepp, Hans Wilhelm ^a   Alber, Guenter ^a   Sheikhzadeh, Abdohlhamid ^a   Schneider, Berthold ^a  

^a KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR;

ADULT; AGED; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPERFUSION;

EID: 0023785747     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(88)80040-8     Document Type: Article

References (14)

1. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction
2. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings
3. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: Prevention by a maintenance infusion
4. Announcement of protocol change in TIMI trial Letter to the editor
5. Intravenous urokinase in acute myocardial infarction
6. The use of single plane angiocardiograms for the calculation of left ventricular volumen in man
7. Coronary artery dimensions from cineangiograms: Methodology and validation of a computer-assisted analysis procedure
8. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
9. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.)
10. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction
11. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
12. Intravenous streptokinase given within 0–4 hours of onset of myocardial infarction reduced mortality in ISIS-2
13. Double-blind trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction
14. A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissuetype plasminogen activator (Activase) in acute myocardial infarction